{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T07:12:42Z","timestamp":1792566762076,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.wneu.2018.06.010","type":"journal-article","created":{"date-parts":[[2018,6,11]],"date-time":"2018-06-11T21:32:50Z","timestamp":1528752770000},"page":"e269-e279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Deregulation of the Hippo Pathway Promotes Tumor Cell Proliferation Through YAP Activity in Human Sporadic Vestibular Schwannoma"],"prefix":"10.1016","volume":"117","author":[{"given":"Fu","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2203-6210","authenticated-orcid":false,"given":"Qiangyi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiyang","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6479-7376","authenticated-orcid":false,"given":"Pinan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2018.06.010_bib1","doi-asserted-by":"crossref","first-page":"6216","DOI":"10.1038\/onc.2010.363","article-title":"Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas","volume":"29","author":"Hadfield","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.wneu.2018.06.010_bib2","first-page":"1533","article-title":"News on the genetics, epidemiology, medical care and translational research of Schwannomas","volume":"253","author":"Hanemann","year":"2006","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.wneu.2018.06.010_bib3","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/S0140-6736(09)60259-2","article-title":"Neurofibromatosis type 2","volume":"373","author":"Asthagiri","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.wneu.2018.06.010_bib4","first-page":"527","article-title":"Improved preservation of hearing and facial nerve function in vestibular schwannoma surgery via the retrosigmoid approach in a series of 200 patients","volume":"105","author":"Samii","year":"2006","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2018.06.010_bib5","first-page":"845","article-title":"Hearing preservation in surgery for large vestibular schwannomas","volume":"111","author":"Wanibuchi","year":"2009","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2018.06.010_bib6","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrneurol.2011.82","article-title":"Emerging therapeutic targets in schwannomas and other merlin-deficient tumors","volume":"7","author":"Ammoun","year":"2011","journal-title":"Nature Reviews Neurol"},{"key":"10.1016\/j.wneu.2018.06.010_bib7","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.febslet.2014.04.001","article-title":"Molecular insights into NF2\/Merlin tumor suppressor function","volume":"588","author":"Cooper","year":"2014","journal-title":"FEBS Let"},{"key":"10.1016\/j.wneu.2018.06.010_bib8","doi-asserted-by":"crossref","first-page":"5236","DOI":"10.1158\/0008-5472.CAN-07-5849","article-title":"Dissecting and targeting the growth factor-dependent and growth factor-independent extracellular signal-regulated kinase pathway in human schwannoma","volume":"68","author":"Ammoun","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.wneu.2018.06.010_bib9","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/onc.2011.357","article-title":"Insulin-like growth factor-binding protein-1 (IGFBP-1) regulates human schwannoma proliferation, adhesion and survival","volume":"31","author":"Ammoun","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.wneu.2018.06.010_bib10","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1083\/jcb.200703010","article-title":"Contact-dependent inhibition of EGFR signaling by Nf2\/Merlin","volume":"177","author":"Curto","year":"2007","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.wneu.2018.06.010_bib11","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nature04856","article-title":"Tumorigenic transformation by CPI-17 through inhibition of a merlin phosphatase","volume":"442","author":"Jin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.wneu.2018.06.010_bib12","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/hmg\/ddg146","article-title":"Upregulation of the Rac1\/JNK signaling pathway in primary human schwannoma cells","volume":"12","author":"Kaempchen","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.wneu.2018.06.010_bib13","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1101\/gad.1054603","article-title":"NF2 deficiency promotes tumorigenesis and metastasis by destabilizing adherens junctions","volume":"17","author":"Lallemand","year":"2003","journal-title":"Genes Dev"},{"key":"10.1016\/j.wneu.2018.06.010_bib14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1534-5807(01)00009-0","article-title":"The Nf2 tumor suppressor, merlin, functions in Rac-dependent signaling","volume":"1","author":"Shaw","year":"2001","journal-title":"Dev Cell"},{"key":"10.1016\/j.wneu.2018.06.010_bib15","doi-asserted-by":"crossref","first-page":"18200","DOI":"10.1073\/pnas.0405971102","article-title":"Neurofibromatosis 2 (NF2) tumor suppressor merlin inhibits phosphatidylinositol 3-kinase through binding to PIKE-L","volume":"101","author":"Rong","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.wneu.2018.06.010_bib16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/ncb1339","article-title":"The tumour-suppressor genes NF2\/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis","volume":"8","author":"Hamaratoglu","year":"2006","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.wneu.2018.06.010_bib17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ccr.2014.05.001","article-title":"Merlin\/NF2 loss-driven tumorigenesis linked to CRL4 (DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus","volume":"26","author":"Li","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.wneu.2018.06.010_bib18","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.cell.2010.01.029","article-title":"Merlin\/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus","volume":"140","author":"Li","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.wneu.2018.06.010_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.devcel.2010.06.015","article-title":"The Merlin\/NF2 tumor suppressor functions through the YAP oncoprotein to regulate tissue homeostasis in mammals","volume":"19","author":"Zhang","year":"2010","journal-title":"Dev Cell"},{"key":"10.1016\/j.wneu.2018.06.010_bib20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nrc2070","article-title":"The Salvador-Warts-Hippo pathway\u2014an emerging tumour-suppressor network","volume":"7","author":"Harvey","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.wneu.2018.06.010_bib21","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.devcel.2010.09.011","article-title":"The hippo signaling pathway in development and cancer","volume":"19","author":"Pan","year":"2010","journal-title":"Dev Cell"},{"key":"10.1016\/j.wneu.2018.06.010_bib22","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1101\/gad.192856.112","article-title":"Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP","volume":"26","author":"Liu-Chittenden","year":"2012","journal-title":"Genes Dev"},{"key":"10.1016\/j.wneu.2018.06.010_bib23","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nrc3458","article-title":"The Hippo pathway and human cancer","volume":"13","author":"Harvey","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.wneu.2018.06.010_bib24","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1002\/cncr.24495","article-title":"Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma","volume":"115","author":"Xu","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.wneu.2018.06.010_bib25","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1111\/j.1349-7006.2010.01511.x","article-title":"Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer","volume":"101","author":"Wang","year":"2010","journal-title":"Cancer Sci"},{"key":"10.1016\/j.wneu.2018.06.010_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1101\/gad.274027.115","article-title":"Mechanisms of Hippo pathway regulation","volume":"30","author":"Meng","year":"2016","journal-title":"Genes Dev"},{"key":"10.1016\/j.wneu.2018.06.010_bib27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.phrs.2015.11.025","article-title":"Targeting the Hippo pathway: clinical implications and therapeutics","volume":"103","author":"Ye","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.wneu.2018.06.010_bib28","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.cell.2013.08.025","article-title":"Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin\/NF2","volume":"154","author":"Yin","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.wneu.2018.06.010_bib29","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1101\/gad.1602907","article-title":"Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control","volume":"21","author":"Zhao","year":"2007","journal-title":"Genes Dev"},{"key":"10.1016\/j.wneu.2018.06.010_bib30","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/embor.2012.11","article-title":"Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus","volume":"13","author":"Li","year":"2012","journal-title":"EMBO Rep"},{"key":"10.1016\/j.wneu.2018.06.010_bib31","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.cell.2012.06.037","article-title":"Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling","volume":"150","author":"Yu","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.wneu.2018.06.010_bib32","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1593\/neo.08642","article-title":"The neurofibromatosis 2 tumor suppressor gene product, merlin, regulates human meningioma cell growth by signaling through YAP","volume":"10","author":"Striedinger","year":"2008","journal-title":"Neoplasia"},{"key":"10.1016\/j.wneu.2018.06.010_bib33","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/NEN.0000000000000238","article-title":"Alterations in the NF2\/LATS1\/LATS2\/YAP pathway in schwannomas","volume":"74","author":"Oh","year":"2015","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"key":"10.1016\/j.wneu.2018.06.010_bib34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1076\/soph.16.4.201.10298","article-title":"Photodynamic therapy with verteporfin: a new treatment in ophthalmology","volume":"16","author":"Michels","year":"2001","journal-title":"Sem Ophthalmol"},{"key":"10.1016\/j.wneu.2018.06.010_bib35","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1158\/0008-5472.CAN-15-1144","article-title":"YAP mediates tumorigenesis in neurofibromatosis type 2 by promoting cell survival and proliferation through a COX-2\u2013EGFR signaling axis","volume":"76","author":"Guerrant","year":"2016","journal-title":"Cancer Res"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875018312245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875018312245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T08:21:20Z","timestamp":1761812480000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875018312245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":35,"alternative-id":["S1878875018312245"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2018.06.010","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deregulation of the Hippo Pathway Promotes Tumor Cell Proliferation Through YAP Activity in Human Sporadic Vestibular Schwannoma","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2018.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}